The ion channel gene, KCNAB2, has been mapped to the 1p36 region and encodes a voltage-gated K+ channel β-subunit protein, Kvβ2 (KCNAB2). K+ channels are major determinants of membrane excitability, and as such, are of particular interest in the context of epilepsy. Native K+ currents are induced by voltage-dependent channels that are composed of tetramers with both α and β subunits. KCNABs can form the pore of the ion channel with α subunits in a 1:1 distribution. Specifically, KCNABs are cytoplasmic proteins that are critical for the correct membrane localization and normal biophysical properties of voltage-gated K+ channels.
Basic Information of KCNAB2 | |
Protein Name | Voltage-gated potassium channel subunit beta-2 |
Gene Name | KCNAB2 |
Aliases | K(+) channel subunit beta-2, Kv-beta-2 |
Organism | Homo sapiens (Human) |
UniProt ID | Q13303 |
Transmembrane Times | / |
Length (aa) | 367 |
Sequence | MYPESTTGSPARLSLRQTGSPGMIYSTRYGSPKRQLQFYRNLGKSGLRVSCLGLGTWVTFGGQITDEMAEQLMTLAYDNGINLFDTAEVYAAGKAEVVLGNIIKKKGWRRSSLVITTKIFWGGKAETERGLSRKHIIEGLKASLERLQLEYVDVVFANRPDPNTPMEETVRAMTHVINQGMAMYWGTSRWSSMEIMEAYSVARQFNLTPPICEQAEYHMFQREKVEVQLPELFHKIGVGAMTWSPLACGIVSGKYDSGIPPYSRASLKGYQWLKDKILSEEGRRQQAKLKELQAIAERLGCTLPQLAIAWCLRNEGVSSVLLGASNADQLMENIGAIQVLPKLSSSIIHEIDSILGNKPYSKKDYRS |
KCNAB2 has been identified as a reasonable candidate gene for epilepsy. It can form a ternary complex with SQSTM1 and PRKCZ. KCNAB2 is an important component of voltage-gated potassium (Kv) channels, which represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. KCNAB2 is one of the beta subunits, which are auxiliary proteins associating with functional Kv-alpha subunits. This member controls the functional properties of the KCNA4 gene product. Alternative splicing of this gene results in two transcript variants encoding distinct isoforms. In melanocytic cells, KCNAB2 gene expression may be regulated by MITF.
The authors show a possible relation between loss of KCNAB2 and the development of seizures. There may be additional genes within 1p36 that contribute to epilepsy in this syndrome. They also suggest that haploinsufficiency for KCNAB2 is a significant risk factor for epilepsy.
This article concludes that Kvbeta2 contributes to the regulation of excitability in vivo. However, Kvbeta2 relies upon as yet unidentified mechanisms in the regulation of K(+) channel and/or oxidoreductive functions.
In this article, they find that deletion of Kcnab2 leads to a reduction in the slow afterhyperpolarization following a burst of action potentials and a concomitant increase in neuronal excitability. Their results suggest that loss of Kvβ2 likely contributes to the cognitive and neurological impairments observed in 1p36DS patients.
In this article, they find that Kcnab2 is located in the 3.1-cM confidence interval containing Bis1 and K+ channels have been shown in involvement of in the genesis of seizures.
We keep in a leading position of membrane protein studies over the past few years. Based on our versatile Magic™ membrane protein production platform, we can provide a series of advanced membrane protein preparation services in reconstitution forms as well as multiple active formats for worldwide customers. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-KCNAB2 antibody development services.
During the past years, Creative Biolabs has successfully generated many functional membrane proteins for our global customers. It’s our duty to promote the development of our clients’ programs with our experienced service. For more details, please feel free to contact us.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.